436 related articles for article (PubMed ID: 9163285)
1. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial.
Sanyal AJ; Freedman AM; Luketic VA; Purdum PP; Shiffman ML; Cole PE; Tisnado J; Simmons S
Ann Intern Med; 1997 Jun; 126(11):849-57. PubMed ID: 9163285
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial.
Cello JP; Ring EJ; Olcott EW; Koch J; Gordon R; Sandhu J; Morgan DR; Ostroff JW; Rockey DC; Bacchetti P; LaBerge J; Lake JR; Somberg K; Doherty C; Davila M; McQuaid K; Wall SD
Ann Intern Med; 1997 Jun; 126(11):858-65. PubMed ID: 9163286
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding.
Russo MW; Zacks SL; Sandler RS; Brown RS
Hepatology; 2000 Feb; 31(2):358-63. PubMed ID: 10655258
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.).
Merli M; Salerno F; Riggio O; de Franchis R; Fiaccadori F; Meddi P; Primignani M; Pedretti G; Maggi A; Capocaccia L; Lovaria A; Ugolotti U; Salvatori F; Bezzi M; Rossi P
Hepatology; 1998 Jan; 27(1):48-53. PubMed ID: 9425916
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
Plaz Torres MC; Best LM; Freeman SC; Roberts D; Cooper NJ; Sutton AJ; Roccarina D; Benmassaoud A; Iogna Prat L; Williams NR; Csenar M; Fritche D; Begum T; Arunan S; Tapp M; Milne EJ; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013122. PubMed ID: 33784794
[TBL] [Abstract][Full Text] [Related]
6. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
[TBL] [Abstract][Full Text] [Related]
7. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.
Lo GH; Liang HL; Chen WC; Chen MH; Lai KH; Hsu PI; Lin CK; Chan HH; Pan HB
Endoscopy; 2007 Aug; 39(8):679-85. PubMed ID: 17661241
[TBL] [Abstract][Full Text] [Related]
8. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding.
Holster IL; Tjwa ET; Moelker A; Wils A; Hansen BE; Vermeijden JR; Scholten P; van Hoek B; Nicolai JJ; Kuipers EJ; Pattynama PM; van Buuren HR
Hepatology; 2016 Feb; 63(2):581-9. PubMed ID: 26517576
[TBL] [Abstract][Full Text] [Related]
9. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding.
Sauer P; Theilmann L; Stremmel W; Benz C; Richter GM; Stiehl A
Gastroenterology; 1997 Nov; 113(5):1623-31. PubMed ID: 9352865
[TBL] [Abstract][Full Text] [Related]
11. TIPS
Korsic S; Stabuc B; Skok P; Popovic P
Radiol Oncol; 2021 Jan; 55(2):164-171. PubMed ID: 33544525
[TBL] [Abstract][Full Text] [Related]
12. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
Brand M; Prodehl L; Ede CJ
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
[TBL] [Abstract][Full Text] [Related]
13. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.
Rössle M; Deibert P; Haag K; Ochs A; Olschewski M; Siegerstetter V; Hauenstein KH; Geiger R; Stiepak C; Keller W; Blum HE
Lancet; 1997 Apr; 349(9058):1043-9. PubMed ID: 9107241
[TBL] [Abstract][Full Text] [Related]
14. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients.
Meddi P; Merli M; Lionetti R; De Santis A; Valeriano V; Masini A; Rossi P; Salvatori F; Salerno F; de Franchis R; Capocaccia L; Riggio O
Hepatology; 1999 Apr; 29(4):1074-7. PubMed ID: 10094949
[TBL] [Abstract][Full Text] [Related]
15. Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial.
Gülberg V; Schepke M; Geigenberger G; Holl J; Brensing KA; Waggershauser T; Reiser M; Schild HH; Sauerbruch T; Gerbes AL
Scand J Gastroenterol; 2002 Mar; 37(3):338-43. PubMed ID: 11916197
[TBL] [Abstract][Full Text] [Related]
16. Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations.
Kravetz D
J Clin Gastroenterol; 2007; 41 Suppl 3():S318-22. PubMed ID: 17975483
[TBL] [Abstract][Full Text] [Related]
17. Balloon-compression endoscopic injection sclerotherapy versus transjugular intrahepatic portosystemic shunt for esophageal variceal rebleeding.
Wu W; Zhang F; Mei X; Zhang Q; Jin J; Kong D
Surg Endosc; 2023 Jul; 37(7):5766-5774. PubMed ID: 37147526
[TBL] [Abstract][Full Text] [Related]
18. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker.
Chen Y; Ma X; Zhang X; Luo J; An L; Zhang Y; Chang X; Dong Z; Zhang W; Kong H; Zhao J; Ding H; Liu F; Yang Y
Hepatol Int; 2022 Dec; 16(6):1379-1389. PubMed ID: 36255564
[TBL] [Abstract][Full Text] [Related]
19. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding.
Bañares R; Casado M; Rodríguez-Láiz JM; Camúñez F; Matilla A; Echenagusía A; Simó G; Piqueras B; Clemente G; Cos E
Am J Gastroenterol; 1998 Jan; 93(1):75-9. PubMed ID: 9448179
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
